Skip to main content

ImmunityBio, Inc.

IBRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001326110

In the last 90 days, ImmunityBio, Inc. insiders filed 0 open-market purchases and 2 sales; 405 institutions reported holding it in 13F filings for Q2 2026, worth $1.76B in total; no superinvestor holds it.

13F holders, Q4 2024

Institutional positions in ImmunityBio, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
202
+24 vs. Q3 2024
Shares held
82.7M
+14.1M (+20.6%) vs. Q3 2024
Total value
$211.8M
−$43.4M (−17.0%) vs. Q3 2024
New holders
44
71 more added
Sold out
20
41 more reduced

4 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting IBRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2024: 202 institutions
Q1 2021: 116 institutionsQ2 2021: 118 institutionsQ3 2021: 121 institutionsQ4 2021: 141 institutionsQ1 2022: 149 institutionsQ2 2022: 132 institutionsQ3 2022: 126 institutionsQ4 2022: 140 institutionsQ1 2023: 147 institutionsQ2 2023: 118 institutionsQ3 2023: 132 institutionsQ4 2023: 148 institutionsQ1 2024: 166 institutionsQ2 2024: 194 institutionsQ3 2024: 182 institutionsQ4 2024: 202 institutionsQ1 2025: 211 institutionsQ2 2025: 242 institutionsQ3 2025: 264 institutionsQ4 2025: 278 institutionsQ1 2026: 386 institutionsQ2 2026: 405 institutions
Value heldQ4 2024: $211.8M
Q1 2021: $378.9MQ2 2021: $390.1MQ3 2021: $310.9MQ4 2021: $209.7MQ1 2022: $199.8MQ2 2022: $123.1MQ3 2022: $196.3MQ4 2022: $256.0MQ1 2023: $84.1MQ2 2023: $108.7MQ3 2023: $84.1MQ4 2023: $288.9MQ1 2024: $356.9MQ2 2024: $391.1MQ3 2024: $255.6MQ4 2024: $211.8MQ1 2025: $239.4MQ2 2025: $327.9MQ3 2025: $352.1MQ4 2025: $338.3MQ1 2026: $1.36BQ2 2026: $1.76B
Institutions holding IBRX and their total value by quarter
QuarterHoldersValue
Q2 2026405$1.76B
Q1 2026386$1.36B
Q4 2025278$338.3M
Q3 2025264$352.1M
Q2 2025242$327.9M
Q1 2025211$239.4M
Q4 2024202$211.8M
Q3 2024182$255.6M
Q2 2024194$391.1M
Q1 2024166$356.9M
Q4 2023148$288.9M
Q3 2023132$84.1M
Q2 2023118$108.7M
Q1 2023147$84.1M
Q4 2022140$256.0M
Q3 2022126$196.3M
Q2 2022132$123.1M
Q1 2022149$199.8M
Q4 2021141$209.7M
Q3 2021121$310.9M
Q2 2021118$390.1M
Q1 2021116$378.9M

Institutions, Q4 2024

Shares, value and share of portfolio for each institution holding ImmunityBio, Inc.; share changes are against Q3 2024.

Institutions holding IBRX in Q4 2024
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.13,584,742$34.8M0.00%+1,727,211+14.6%Added
Vanguard Group Inc17,328,229$44.4M0.00%+425,713+2.5%Added
D. E. Shaw & Co., Inc.0$00.00%−520,053−100.0%Sold out
HarbourVest Partners LLC0$00.00%−335,709−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−135,029−100.0%Sold out
Squarepoint Ops LLC0$00.00%−109,485−100.0%Sold out
Sherbrooke Park Advisers LLC0$00.00%−75,078−100.0%Sold out
Advantage Alpha Capital Partners LP0$00.00%−69,207−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−65,811−100.0%Sold out
Caption Management, LLC0$00.00%−26,032−100.0%Sold out
Catalyst Funds Management Pty Ltd0$00.00%−20,600−100.0%Sold out
Integrated Wealth Concepts LLC0$00.00%−17,158−100.0%Sold out
Cambridge Investment Research Advisors, Inc.0$00.00%−14,519−100.0%Sold out
Virtu Financial LLC0$00.00%−13,608−100.0%Sold out
Acadian Asset Management LLC0$00.00%−12,432−100.0%Sold out
Captrust Financial Advisors0$00.00%−11,073−100.0%Sold out
Susquehanna Portfolio Strategies, LLC0$00.00%−10,392−100.0%Sold out
Arcadia Investment Management Corp0$00.00%−1,000−100.0%Sold out
Clear Street Markets LLC0$00.00%−897−100.0%Sold out
Headlands Technologies LLC0$00.00%−264−100.0%Sold out
MeadowBrook Investment Advisors LLC0$00.00%−200−100.0%Sold out
Fortitude Family Office, LLC0$00.00%−95−100.0%Sold out
Winning Points Advisors, LLC––––Not filed
Raymond James & Associates––––Not filed
Raymond James Financial Services Advisors, Inc.––––Not filed
Planning Capital Management Corp––––Not filed